Arthrose et diabète : pourquoi ? Les données fondamentales
暂无分享,去创建一个
[1] D. A. van der Windt,et al. Metabolic risk factors and the incidence and progression of radiographic hand osteoarthritis: a population-based cohort study , 2018, Scandinavian journal of rheumatology.
[2] D. Felson,et al. Association Between Metabolic Syndrome and Radiographic Hand Osteoarthritis: Data From a Community‐Based Longitudinal Cohort Study , 2018, Arthritis care & research.
[3] H. Schaible,et al. Pain sensation in human osteoarthritic knee joints is strongly enhanced by diabetes mellitus , 2017, Pain.
[4] F. Berenbaum,et al. The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes–associated osteoarthritis , 2017, The Journal of Biological Chemistry.
[5] D. A. van der Windt,et al. Does metformin protect against osteoarthritis? An electronic health record cohort study , 2017, Primary Health Care Research & Development.
[6] V. Shirinsky,et al. Effects of medication-treated diabetes on incidence and progression of knee osteoarthritis: a longitudinal analysis of the Osteoarthritis Initiative data , 2017, Rheumatology International.
[7] J. Sellam,et al. Osteoarthritis and type 2 diabetes mellitus: What are the links? , 2016, Diabetes research and clinical practice.
[8] Daniel A. London,et al. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. , 2016, Journal of diabetes and its complications.
[9] S. Kates,et al. Suppressive Effects of Insulin on Tumor Necrosis Factor–Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus , 2016, Arthritis & rheumatology.
[10] J. Wang,et al. Role of PPARα in down-regulating AGE-induced TGF-β and MMP-9 expressions in chondrocytes. , 2016, Genetics and molecular research : GMR.
[11] B. Al‐Ani,et al. Insulin and vanadium protect against osteoarthritis development secondary to diabetes mellitus in rats , 2016, Archives of physiology and biochemistry.
[12] F. Berenbaum,et al. Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis. , 2015, Osteoarthritis and cartilage.
[13] F. Berenbaum,et al. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis , 2015, RMD Open.
[14] A. Hartemann,et al. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes , 2014, Diabetes/metabolism research and reviews.
[15] R. Wu,et al. Characterisation of osteoarthritis in a small animal model of type 2 diabetes mellitus , 2014, Bone & joint research.
[16] K. Tsai,et al. Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products , 2013, PloS one.
[17] A. Iagnocco,et al. Diabetes Is an Independent Predictor for Severe Osteoarthritis , 2013, Diabetes Care.
[18] Kozo Nakamura,et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. , 2012, Osteoarthritis and cartilage.
[19] F. Berenbaum. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype , 2011, Annals of the rheumatic diseases.
[20] J. Pelletier,et al. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways. , 2007, Arthritis and rheumatism.
[21] B. Koes,et al. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study , 2007, Annals of the rheumatic diseases.
[22] Allison E. Williams,et al. Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes. , 2011, Journal of rehabilitation research and development.
[23] Alice Maroudas,et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. , 2002, Arthritis and rheumatism.